Product Information

MYCOPHENOLIC ACID DR 360 MG TB is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.2371 per EA under NDC 70436017323. Its NADAC has been published 242 times since Oct 6, 2021.

FDA first approved this application on Feb 10, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Mycophenolic Acid market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

MYCOPHENOLIC ACID DR 360 MG TB

Mycophenolic Acid
$0.2371per EA
High Outlier

Strength

360 mg/1

NDC

70436017323

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

5/20/2026

Active Ingredients

MYCOPHENOLATE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA214376

FDA Approved

2/10/2021

TE Code

AB

On Market Since

5/19/2021

Pharmacological Classes

Price Statistics

The NADAC for MYCOPHENOLIC ACID DR 360 MG TB has been published 242 times since Oct 6, 2021, and over the history we have for it it has declined 80.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2371 per EA
All-time high$1.3958 (Nov 10, 2021)
All-time low$0.2114 (Jul 17, 2024)
52-week high$0.2624
52-week low$0.2223
Median price$0.3097
Average price$0.4155
Largest weekly change-43.2% (Mar 23, 2022)
Weeks tracked242
Tracking sinceOct 6, 2021

Price History

1W

N/A

1M

N/A

3M

N/A

6M

+2.8%

1Y

-9.6%

3Y

-37.6%

5Y

N/A

All

-80.1%

Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of MYCOPHENOLIC ACID DR 360 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for MYCOPHENOLIC ACID DR 360 MG TB, manufactured by Slate Run Pharmaceuticals LLC, is $0.2371 per EA (NDC 70436017323), effective May 20, 2026.

How has the price of MYCOPHENOLIC ACID DR 360 MG TB changed over time?

Over the history we have for it, the NADAC for MYCOPHENOLIC ACID DR 360 MG TB has declined 80.1%. It has been tracked across 242 weekly CMS publications since Oct 6, 2021.

What are the highest and lowest recorded NADAC prices for MYCOPHENOLIC ACID DR 360 MG TB?

Since Oct 6, 2021, the NADAC for MYCOPHENOLIC ACID DR 360 MG TB has ranged from a low of $0.2114 (Jul 17, 2024) to a high of $1.3958 (Nov 10, 2021), with a median of $0.3097 per EA.

Are there cheaper alternatives to MYCOPHENOLIC ACID DR 360 MG TB?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MYCOPHENOLIC ACID DR 360 MG TB, is $0.2265 per EA — about 4% below MYCOPHENOLIC ACID DR 360 MG TB.

Who manufactures MYCOPHENOLIC ACID DR 360 MG TB?

MYCOPHENOLIC ACID DR 360 MG TB (NDC 70436017323) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.